These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1296489)

  • 1. [Pharmacotoxicological profile of a non-ionic LOCM at high hydrophilicity: ioversol].
    Doucet D; Idée JM
    Ann Radiol (Paris); 1992; 35(4 Pt 2):267-72. PubMed ID: 1296489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical tolerability of ioversol 300 in brain computed tomography].
    Gillard C; Tatu L; Menegazzo D; Bonneville JF
    Ann Radiol (Paris); 1992; 35(4 Pt 2):284-7. PubMed ID: 1296493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic versus nonionic contrast media: a prospective study of the effect of rapid bolus injection on nausea and anaphylactoid reactions.
    Federle MP; Willis LL; Swanson DP
    J Comput Assist Tomogr; 1998; 22(3):341-5. PubMed ID: 9606371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of ioversol in the dog and rat.
    Ralston WH; Robbins MS; Coveney JR
    Invest Radiol; 1989 Jun; 24 Suppl 1():S10-5. PubMed ID: 2592167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (Optiray).
    Le Mignon MM; Azau C; Arthaud A; Bonnemain B
    Eur J Radiol; 1991; 13(2):126-33. PubMed ID: 1743190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of intravenous injection of ioversol, a nonionic contrast medium, on circulating blood volume: comparison among different combinations of its dose and volume injected].
    Sakuma I; Sakuma K; Fukao M; Akaishi Y; Asajima H; Sato M; Shudo H; Numazawa K; Kakinoki S; Kitabatake A
    Kokyu To Junkan; 1993 Dec; 41(12):1191-5. PubMed ID: 8284543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
    Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
    Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of iopamidol and ioversol in vitro and in animal studies.
    Krause W; Miyazawa T; Uchimoto R; Murayama C; Fritz-Zieroth B; Press WR; Frenzel T
    Arzneimittelforschung; 1995 Feb; 45(2):200-4. PubMed ID: 7710450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of ioversol in healthy volunteers.
    Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
    Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
    Joffre F; Rousseau H; Aziza R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):288-92. PubMed ID: 1296494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of diagnostic efficacy and clinical tolerability of ioversol in "whole body" computed tomography in children. A non comparative phase III trial].
    Panuel M; Devred P; Faure F; Bourlière-Najean B; Ternier F; Le Bail C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):280-3. PubMed ID: 1296492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ioversol 300: clinical study in pediatric intravenous urography].
    Montagne J; Adamsbaum C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):307-10. PubMed ID: 1296498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of efficacy and tolerability of ioversol in intravenous urography].
    Lemaître L
    Ann Radiol (Paris); 1992; 35(4 Pt 2):303-6. PubMed ID: 1296497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental and clinical determination of renal size after intravenous and intra-arterial administration of ionic and non-ionic contrast media].
    Helzel MV; Wolf GK; Prager P
    Rofo; 1985 Mar; 142(3):333-7. PubMed ID: 2984739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subacute toxicity studies of ioversol in experimental animals.
    Ralston WH; Robbins MS; Coveney J; Blair M
    Invest Radiol; 1989 Jun; 24 Suppl 1():S2-9. PubMed ID: 2592169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced side effects of low osmolality non-ionic contrast media in coronary arteriography. Comparative experimental study in dogs.
    Schräder R; Baller D; Hoeft A; Korb H; Wolpers HG; Hellige G
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():67-77. PubMed ID: 6139083
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ionic and non-ionic contrast media after selective peripheral and cerebral arterial injections in rats.
    Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():62-6. PubMed ID: 6139082
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplacental passage of non-ionic contrast agents resulting in fetal bowel opacification: a mimic of pneumoperitoneum in the newborn.
    Hill BJ; Saigal G; Patel S; Abdenour GE
    Pediatr Radiol; 2007 Apr; 37(4):396-8. PubMed ID: 17323055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.